BioSynTech Malaysia Group Sdn Bhd |

03 May [MCE] Unlocking the Future of Cancer Research_12 Innovative Agents Shine at AACR 2024

Posted at 09:17h in News by Editorial BSTM

0 Likes

The 2024 AACR meeting wrapped up successfully in California, USA, showcasing the latest in innovative agents poised to enter clinical trials for cancer treatment. The spotlight was on key targets such as CDK, KRAS, and WRN, covering various types of cancers and therapeutic approaches. Dominating the...

03 May [MCE] Small Molecules for Cell and Gene Therapy (CGT)

Posted at 09:06h in News by Editorial BSTM

0 Likes

Cell and Gene Therapy (CGT) With advancements in science and technology, the demand for precision in disease treatment is growing. Cell and Gene Therapies (CGT) were developed from years of research in life science. They use a wide range of molecular techniques to manipulate gene expression...

03 May [MCE] Oligonucleotide Therapeutics on the Rise

Posted at 08:04h in News by Editorial BSTM

0 Likes

Oligonucleotides are specially designed sequences of nucleotides, which can be used as antisense oligonucleotides (ASOs), small interfering RNA (siRNA), microRNA (miRNA), aptamers, etc. Oligonucleotides can hybridize with target gene mRNA or pre-mRNA through complementary base pairing and modulate gene expression via various processes, including RNA interference...

03 May [MCE] Immune Checkpoint Proteins, Key Players in Tumor Immunity

Posted at 07:51h in News by Editorial BSTM

0 Likes

Immune checkpoint (IC) proteins are key molecules that regulate the immune system by maintaining immune tolerance, determining the timing of the immune response, and controlling the intensity of the immune stress. Tumor cells exploit the immune checkpoint pathway as a major mechanism for immune escape,...

03 May [MCE] New Bioactive Molecules for April 2024

Posted at 06:29h in News by Editorial BSTM

0 Likes

MedChemExpress (MCE) provides a wide range of life-science biochemicals, including more than 100,000 bioactive compounds, dye reagents, peptides and natural compounds for laboratory and scientific use. If you need these products, please do not hesitate to contact us via CAS No.: 1421854-16-1 AC-186 Research Area: Estrogen Receptor/ERR/Neurological Disease • A...

Contact Us

Social Media

May 2024

03 May [MCE] Unlocking the Future of Cancer Research_12 Innovative Agents Shine at AACR 2024

03 May [MCE] Small Molecules for Cell and Gene Therapy (CGT)

03 May [MCE] Oligonucleotide Therapeutics on the Rise

03 May [MCE] Immune Checkpoint Proteins, Key Players in Tumor Immunity

03 May [MCE] New Bioactive Molecules for April 2024

Site Map

Sign Up for Our Newsletter

Social Media

Contact Us

ABOUT US